[1]
Alkaabba, F., Li, H. and Ibrahim, F. 2022. Activating dormant strongyloidiasis secondary to COVID-19 treatment. Global Journal of Medical and Clinical Case Reports. 9, 1 (Feb. 2022), 015–017. DOI:https://doi.org/10.17352/2455-5282.000148.